Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

In view of the increasing number of patients treated with breast-conserving treatment (BCT) for ductal carcinoma-in-situ (DCIS), risk factors for recurrence and metastasis should be identified.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Clin Oncol

Title: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Publisher: American Society of Clinical Oncology (ASCO)

ISSN: 0732-183X

ISSN (Print): 0732-183X

Publication date (Electronic): Apr 15 2001

Volume: 19

Issue: 8

Affiliations

[1 ] Departments of Radiation Oncology and Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands.

Article

DOI: 10.1200/JCO.2001.19.8.2263

PubMed ID: 11304780

SO-VID: 45ce5928-5490-42c7-90e5-2e9e623dddfe

History

Data availability:

Comments

Comment on this article

scite_

Cited by 70

See all cited by

- Version 1